<SEC-DOCUMENT>0000950170-24-063689.txt : 20240523
<SEC-HEADER>0000950170-24-063689.hdr.sgml : 20240523
<ACCEPTANCE-DATETIME>20240522190623
ACCESSION NUMBER:		0000950170-24-063689
CONFORMED SUBMISSION TYPE:	S-8 POS
PUBLIC DOCUMENT COUNT:		6
FILED AS OF DATE:		20240523
DATE AS OF CHANGE:		20240522
EFFECTIVENESS DATE:		20240523

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Viking Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001607678
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				461073877
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8 POS
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-236666
		FILM NUMBER:		24974848

	BUSINESS ADDRESS:	
		STREET 1:		9920 PACIFIC HEIGHTS BLVD, SUITE 350
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-704-4660

	MAIL ADDRESS:	
		STREET 1:		9920 PACIFIC HEIGHTS BLVD, SUITE 350
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8 POS
<SEQUENCE>1
<FILENAME>vktx-form_s-8_pos_333-23.htm
<DESCRIPTION>S-8 POS
<TEXT>
<html>
 <head>
  <title>S-8 POS</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div style="min-height:1in;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As filed with the Securities and Exchange Commission on May 22, 2024</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Registration No. 333-203810</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Registration No. 333-211270</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Registration No. 333-216857</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Registration No. 333-223503</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Registration No. 333-230247</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Registration No. 333-236666</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Registration No. 333-253219</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Registration No. 333-262609</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Registration No. 333-269675</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Registration No. 333-276939</font></p>
  <p style="font-size:10pt;margin-top:4pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><br></font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:16pt;font-family:Times New Roman;min-width:fit-content;">UNITED STATES</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:16pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:16pt;font-family:Times New Roman;min-width:fit-content;">SECURITIES AND EXCHANGE COMMISSION</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:16pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Washington, D.C. 20549</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:12pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:16pt;font-family:Times New Roman;min-width:fit-content;">POST EFFECTIVE AMENDMENT NO. 1 TO:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">FORM S-8 REGISTRATION STATEMENT NO. 333-203810</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">FORM S-8 REGISTRATION STATEMENT NO. 333-211270</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">FORM S-8 REGISTRATION STATEMENT NO. 333-216857</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">FORM S-8 REGISTRATION STATEMENT NO. 333-223503</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">FORM S-8 REGISTRATION STATEMENT NO. 333-230247</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">FORM S-8 REGISTRATION STATEMENT NO. 333-236666</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">FORM S-8 REGISTRATION STATEMENT NO. 333-253219</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">FORM S-8 REGISTRATION STATEMENT NO. 333-262609</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">FORM S-8 REGISTRATION STATEMENT NO. 333-269675</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">FORM S-8 REGISTRATION STATEMENT NO. 333-276939</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">UNDER</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">THE SECURITIES ACT OF 1933</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:24pt;font-family:Times New Roman;min-width:fit-content;">Viking Therapeutics, Inc.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:24pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(Exact name of registrant as specified in its charter)</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:50.5%;"></td>
    <td style="width:1.02%;"></td>
    <td style="width:48.48%;"></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:middle;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Delaware</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">46-1073877</font></p></td>
   </tr>
   <tr style="height:8pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(State or other jurisdiction of</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">incorporation or organization)</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:bottom;padding-bottom:0.003in;padding-right:0.003in;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-top:0.003in;padding-left:0.003in;vertical-align:top;padding-bottom:0.003in;padding-right:0.003in;text-align:left;"><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(I.R.S. Employer</font></p><p style="font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:1pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Identification No.)</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">9920 Pacific Heights Blvd, Suite 350</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">San Diego, CA 92121 </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(Address of Principal Executive Offices) (Zip Code)</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"><br>2024 Equity Incentive Plan</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(Full title of the plan)</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Brian Lian, Ph.D.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">President and Chief Executive Officer</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Viking Therapeutics, Inc.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">9920 Pacific Heights Blvd, Suite 350</font></p>
  <div style="flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;"></div>
  <hr style="page-break-after:always;">
  <div style="min-height:1in;"></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">San Diego, CA 92121</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(858) 704-4660</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(Name, address and telephone number, including area code, of agent for service)</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Copies to:</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Jeffrey T. Hartlin, Esq. <br>Samantha H. Eldredge, Esq.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Paul Hastings LLP</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">1117 S. California Avenue</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Palo Alto, California 94304 <br>(650) 320-1800</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#x201c;large accelerated filer,&#x201d; &#x201c;accelerated filer,&#x201d; &#x201c;smaller reporting company&#x201d; and &#x201c;emerging growth company&#x201d; in Rule 12b-2 of the Exchange Act.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:50%;"></td>
    <td style="width:50%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Large accelerated filer </font><font style="color:#000000;white-space:pre-wrap;font-family:'Segoe UI Symbol',sans-serif;min-width:fit-content;">&#9746;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Accelerated filer </font><font style="color:#000000;white-space:pre-wrap;font-family:'Segoe UI Symbol',sans-serif;min-width:fit-content;">&#9744;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Non-accelerated filer   </font><font style="color:#000000;white-space:pre-wrap;font-family:'Segoe UI Symbol',sans-serif;min-width:fit-content;">&#9744;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Smaller reporting company </font><font style="color:#000000;white-space:pre-wrap;font-family:'Segoe UI Symbol',sans-serif;min-width:fit-content;">&#9744;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Emerging growth company </font><font style="color:#000000;white-space:pre-wrap;font-family:'Segoe UI Symbol',sans-serif;min-width:fit-content;">&#9744;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="2" style="padding-left:0.075in;vertical-align:top;padding-right:0.075in;"><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. </font><font style="color:#000000;white-space:pre-wrap;font-family:'Segoe UI Symbol',sans-serif;min-width:fit-content;">&#9744;</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="flex-direction:column;display:flex;min-height:1in;justify-content:flex-end;"></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">EXPLANATORY NOTE</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to Securities Act Forms Compliance and Disclosure Interpretation 126.43 (&#x201c;C&amp;DI 126.43&#x201d;) published by the Securities and Exchange Commission (the &#x201c;Commission&#x201d;), Viking Therapeutics, Inc. (the &#x201c;Registrant&#x201d;) is filing this Post-Effective Amendment No. 1 to Registration Statements on Form S-8 (this &#x201c;Post-Effective Amendment&#x201d;) to the following registration statements on Form S-8 (collectively, the &#x201c;Prior Registration Statements&#x201d;) filed by the Registrant with the Commission:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">1)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Registration Statement on Form S-8 (File No. 333-203810) filed on May 1, 2015, with respect to 1,527,770 shares of the Registrant&#x2019;s common stock, $0.001 par value per share (&#x201c;Common Stock&#x201d;) issued or issuable under the Viking Therapeutics, Inc. 2014 Equity Incentive Plan, as amended (the &#x201c;2014 Plan&#x201d;); </font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">2)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Registration Statement on Form S-8 (File No. 333-211270) filed on May 10, 2016, with respect to 338,930 shares of Common Stock issued or issuable under the 2014 Plan; </font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">3)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Registration Statement on Form S-8 (File No. 333-216857) filed on March 21, 2017, with respect to 728,835 shares of Common Stock issued or issuable under the 2014 Plan; </font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">4)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Registration Statement on Form S-8 (File No. 333-223503) filed on March 7, 2018, with respect to 1,253,598 shares of Common Stock issued or issuable under the 2014 Plan; </font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">5)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Registration Statement on Form S-8 (File No. 333-230247) filed on March 13, 2019, with respect to 2,510,971 shares of Common Stock to issued or issuable under the 2014 Plan;</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">6)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Registration Statement on Form S-8 (File No. 333-236666) filed on February 26, 2020, with respect to 2,534,476 shares of Common Stock issued or issuable under the 2014 Plan;</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">7)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Registration Statement on Form S-8 (File No. 333-253219) filed on February 17, 2021, with respect to 2,562,557 shares of Common Stock issued or issuable under the 2014 Plan;</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">8)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Registration Statement on Form S-8 (File No. 333-262609) filed on February 9, 2022, with respect to 2,738,694 shares of Common Stock issued or issuable under the 2014 Plan;</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">9)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Registration Statement on Form S-8 (File No. 333-269675) filed on February 10, 2023, with respect to 2,739,004 shares of Common Stock issued or issuable under the 2014 Plan; and </font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">10)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Registration Statement on Form S-8 (File No. 333-276939) filed on February 7, 2024, with respect to 3,503,981 shares of Common Stock issued or issuable under the 2014 Plan.</font></div></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On May 21, 2024, the Registrant&#x2019;s stockholders approved the Viking Therapeutics, Inc. 2024 Equity Incentive Plan (the &#x201c;2024 Plan&#x201d;), which replaces the 2014 Plan. No further awards will be made under the 2014 Plan.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The number of shares of Common Stock initially authorized for issuance pursuant to the awards under the 2024 Plan is equal to (a) 12,000,000 shares of Common Stock, plus (b) up to 7,674,614 shares of Common Stock currently subject to outstanding stock options or other equity awards granted under the Viking Therapeutics, Inc. 2014 Equity Incentive Plan (the &#x201c;2014 Plan&#x201d;) that would become available for future issuance under the 2024 Plan to the extent that, after the date hereof, any such equity award terminates or expires prior to exercise or settlement, is not issued because the award is settled in cash, is forfeited because of the failure to vest or is reacquired or withheld (or not issued) to satisfy a tax withholding obligation or the purchase or exercise price (such shares under clause (b), the &#x201c;Carryover Shares&#x201d;).</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Contemporaneously with the filing of this Post-Effective Amendment, the Registrant is filing a Registration Statement on Form S-8 to register the 12,000,000 newly authorized shares of Common Stock that have become available for offer or sale pursuant to the 2024 Plan, which number does not include the Carryover Shares.</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In accordance with C&amp;DI 126.43 and pursuant to the undertaking in Item 512(a)(1)(iii) of Regulation S-K that the Registrant disclose a material change in the plan of distribution as it was originally disclosed in the Prior Registration Statements, this Post-Effective Amendment is filed to indicate that the Prior Registration Statements will also cover the issuance of the Carryover Shares under the 2024 Plan (as such shares would no longer be issuable under the 2014 Plan as described above). No additional securities are being registered by this Post-Effective Amendment.</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:24pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">PART I</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The information specified in Item 1 and Item 2 of Part I of Form S-8 is omitted from this Post-Effective Amendment in accordance with the provisions of Rule 428 under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;), and the introductory note to Part I of Form S-8.  The document(s) containing the information specified in Part I will be sent or given to participants in the equity plans covered by this Post-Effective Amendment as specified by Rule 428(b)(1) of the Securities Act.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">PART II</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ITEM 3. INCORPORATION OF DOCUMENTS BY REFERENCE.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The following documents filed by the Registrant with the Securities and Exchange Commission (the &#x201c;SEC&#x201d;) are hereby incorporated by reference into this Registration Statement:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:3.039%;"></td>
    <td style="width:5.059%;"></td>
    <td style="width:91.902%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(a)</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">The Registrant&#x2019;s Annual Report on </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001607678/000095017024012322/vktx-20231231.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Form 10-K</font></a><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-family:Arial;min-width:fit-content;">f</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">or the fiscal year ended December 31, 2023 filed with the SEC on February 7, 2024;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(b)</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">The Registrant&#x2019;s Quarterly Report on </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1607678/000095017024047833/vktx-20240331.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Form 10-Q</font></a><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;for the quarter ended March 31, 2024 filed with the SEC on April 25, 2024;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(c)</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">The information specifically incorporated by reference into the Registrant&#x2019;s Annual Report on Form 10-K for the fiscal year ended December 31, 2023 from the Registrant&#x2019;s revised definitive proxy statement on </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001607678/000095017024042251/vktx-20240405.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Schedule 14A</font></a><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">, filed with the SEC on April 5, 2024;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(d)</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">The Registrant&#x2019;s Current Reports on Form 8-K filed with the SEC on </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001607678/000095017024023838/vktx-20240228.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">March 1, 2024</font></a><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;and </font><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001607678/000095017024024878/vktx-20240304.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">March 4, 2024</font></a><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">; and</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(e)</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">The description of the Registrant&#x2019;s common stock set forth in the Registration Statement on </font><a href="https://www.sec.gov/Archives/edgar/data/1607678/000119312515143612/d914659d8a12b.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Form 8-A</font></a><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;filed with the SEC on April 23, 2015 (File No. 001-37355) pursuant to Section 12(b) of the Securities Exchange Act of 1934, as amended (the &#x201c;Exchange Act&#x201d;), including any amendments or reports filed for the purpose of updating such description, including the description of common stock contained in </font><a href="https://www.sec.gov/Archives/edgar/data/1607678/000156459023001685/vktx-ex42_8.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Exhibit 4.2</font></a><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">&#160;of the Registrant&#x2019;s Annual Report on Form 10-K for the fiscal year ended December 31, 2022, filed with the SEC on February 10, 2023.</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">All other reports and other documents subsequently filed by the Registrant pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934, as amended (the &#x201c;Exchange Act&#x201d;), prior to the filing of a post-effective amendment which indicates that all securities offered hereby have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference into this Registration Statement and to be a part of this Registration Statement from the date of the filing of such reports and documents, except as to any portion of any future annual or quarterly report to stockholders or document or current report furnished under Items 2.02 or 7.01 of Form 8-K that is not deemed filed under such provisions.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">For the purposes of this Registration Statement, any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded to the extent that a statement contained herein or in any other subsequently filed document that also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">You should rely only on the information provided or incorporated by reference in this Registration Statement or any related prospectus. The Registrant has not authorized anyone to provide you with different information. You should not assume that the information in this Registration Statement or any related prospectus is accurate as of any date other than the date on the front of the document.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">You may contact the Registrant in writing or orally to request copies of the above-referenced filings, without charge (excluding exhibits to such documents unless such exhibits are specifically incorporated by reference into the information incorporated into this Registration Statement). Requests for such information should be directed to:</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Viking Therapeutics, Inc.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">9920 Pacific Heights Blvd, Suite 350</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">San Diego, CA 92121</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(858) 704-4660</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Attn: Chief Executive Officer</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ITEM 4. DESCRIPTION OF SECURITIES.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Not applicable.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ITEM 5. INTERESTS OF NAMED EXPERTS AND COUNSEL.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Not applicable.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ITEM 6. INDEMNIFICATION OF DIRECTORS AND OFFICERS.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Section 145 of the General Corporation Law of the State of Delaware, or the DGCL, authorizes a corporation&#x2019;s board of directors to grant, and authorizes a court to award, indemnity to officers, directors and other corporate agents.</font></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">As permitted by Section 102(b)(7) of the DGCL, the Registrant&#x2019;s amended and restated certificate of incorporation and amended and restated bylaws contain provisions that limit the liability of the Registrant&#x2019;s directors for monetary damages to the fullest extent permitted by Delaware law. Consequently, the Registrant&#x2019;s directors are not personally liable to the Registrant or the Registrant&#x2019;s stockholders for monetary damages for any breach of fiduciary duties as directors, except liability for the following:</font></p>
  <div style="margin-left:3.333%;display:flex;margin-top:9pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">any breach of their duty of loyalty to the Registrant or the Registrant&#x2019;s stockholders;</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:9pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law;</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:9pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">unlawful payments of dividends or unlawful stock repurchases or redemptions as provided in Section 174 of the DGCL; or</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:9pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:3.447919145106397%;display:inline-flex;justify-content:flex-start;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">any transaction from which they derived an improper personal benefit.</font></div></div>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Any amendment to, or repeal of, these provisions will not eliminate or reduce the effect of these provisions in respect of any act, omission or claim that occurred or arose prior to that amendment or repeal. If the DGCL is amended to provide for further limitations on the personal liability of directors of corporations, then the personal liability of the Registrant&#x2019;s directors will be further limited to the greatest extent permitted by the DGCL.</font></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Registrant&#x2019;s amended and restated certificate of incorporation provides that the Registrant will, under certain circumstances, indemnify any director, officer, employee or agent of the Registrant, subject to any provisions contained in the Registrant&#x2019;s amended and restated bylaws. The Registrant&#x2019;s amended and restated bylaws provide that the Registrant will indemnify, to the fullest extent permitted by law, each person who was or is made a party or is threatened to be made a party to, or is otherwise involved in, any action, suit or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that he or she, or a person for whom he or she is the legal representative, is or was a director or officer of the Registrant, or is or was serving at the request of the Registrant, as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against all expense, liability and loss (including, among other things, attorney&#x2019;s fees and amounts paid in settlement) reasonably incurred or suffered by such director, officer, employee or agent in connection therewith, subject to certain conditions. The Registrant&#x2019;s amended and restated bylaws also provide the Registrant with the power to, to the extent authorized by the Registrant&#x2019;s board of directors, grant rights to indemnification and to advancement of expenses to any employee or agent of the Registrant to the fullest extent indemnification may be granted to the Registrant&#x2019;s directors and officers. In addition, the Registrant&#x2019;s amended and restated bylaws provide</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">that the Registrant must advance expenses incurred by or on behalf of a director or officer in advance of the final disposition of any action or proceeding, subject to certain exceptions.</font></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Registrant has entered into separate indemnification agreements with each of its directors and executive officers that may be broader than the specific indemnification provisions contained in the DGCL. These indemnification agreements require the Registrant, among other things, to indemnify its directors and executive officers against liabilities that may arise by reason of their status or service. These indemnification agreements also require the Registrant to advance all expenses incurred by the directors and executive officers in investigating or defending any such action, suit or proceeding, subject to certain exceptions. The Registrant believes that these agreements are necessary to attract and retain qualified individuals to serve as directors and executive officers.</font></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The limitation of liability and indemnification provisions that are included in the Registrant&#x2019;s amended and restated certificate of incorporation, amended and restated bylaws and indemnification agreements with its directors and executive officers may discourage stockholders from bringing a lawsuit against the Registrant&#x2019;s directors and executive officers for breach of their fiduciary duties. They may also reduce the likelihood of derivative litigation against the Registrant&#x2019;s directors and executive officers even though an action, if successful, might benefit the Registrant and other stockholders. Further, a stockholder&#x2019;s investment may be adversely affected to the extent that the Registrant pays the costs of settlement and damage awards against directors and executive officers as required by these indemnification provisions. At present, the Registrant is not aware of any pending litigation or proceeding involving any person who is or was one of its directors, officers, employees or other agents or is or was serving at its request as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, for which indemnification is sought, and the Registrant is not aware of any threatened litigation that may result in claims for indemnification.</font></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Registrant&#x2019;s amended and restated bylaws provide that the Registrant may purchase and maintain insurance, at its expense, to protect itself and any person who is or was a director, officer, employee or agent of the Registrant or is or was serving at its request as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against any expense, liability or loss, whether or not the Registrant would have the power to indemnify such person against such expense, liability or loss under the DGCL. The Registrant maintains insurance under which, subject to the limitations of the insurance policies, coverage is provided to the Registrant&#x2019;s directors and executive officers against loss arising from claims made by reason of breach of fiduciary duty or other wrongful acts as a director or executive officer, including claims relating to public securities matters, and to the Registrant with respect to payments that may be made by the Registrant to these directors and executive officers pursuant to the Registrant&#x2019;s indemnification obligations or otherwise as a matter of law.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ITEM 7. EXEMPTION FROM REGISTRATION CLAIMED.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Not applicable.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ITEM 8. EXHIBITS.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:8%;"></td>
    <td style="width:2%;"></td>
    <td style="width:90%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Exhibit Number</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">  </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Description</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.1</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1607678/000119312514257855/d711611dex33.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Amended and Restated Certificate of Incorporation (previously filed on July 1, 2014 as Exhibit 3.3 to the Registrant&#x2019;s Registration Statement on Form S-1 (File No. 333-197182) and incorporated herein by reference).</font></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">3.2</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1607678/000095017023021359/vktx-ex3_1.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Amended and Restated Bylaws of Viking Therapeutics, Inc., effective as of May 9, 2023 (previously filed on May 11, 2023 as Exhibit 3.1 to the Registrant's Current Report on Form 8-K and incorporated herein by reference).</font></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.1</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1607678/000119312514257855/d711611dex41.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Form of Common Stock Certificate (previously filed on July 1, 2014 as Exhibit 4.1 to the Registrant&#x2019;s Registration Statement on Form S-1 (File No. 333-197182) and incorporated herein by reference).</font></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
  </table>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:8%;"></td>
    <td style="width:2%;"></td>
    <td style="width:90%;"></td>
   </tr>
   <tr style="height:10pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.2</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1607678/000119312515071007/d770501dex102.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">2014 Equity Incentive Plan (previously filed on March 2, 2015 as Exhibit 10.2 to the Registrant&#x2019;s Registration Statement on Form S-1/A (File No. 333-197182) and incorporated herein by reference).</font></a></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.3</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1607678/000119312514257855/d711611dex103.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Form of Stock Option Award Agreement (2014 Equity Incentive Plan) (previously filed on July 1, 2014 as Exhibit 10.3 to the Registrant&#x2019;s Registration Statement on Form S-1 (File No. 333-197182) and incorporated herein by reference).</font></a></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.4</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1607678/000119312514257855/d711611dex104.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Form of Restricted Stock Unit Award Agreement (2014 Equity Incentive Plan) (previously filed on July 1, 2014 as Exhibit 10.4 to the Registrant&#x2019;s Registration Statement on Form S-1 (File No. 333-197182) and incorporated herein by reference).</font></a></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.5</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1607678/000119312514257855/d711611dex105.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Form of Stock Appreciation Rights Award Agreement (2014 Equity Incentive Plan) (previously filed on July 1, 2014 as Exhibit 10.5 to the Registrant&#x2019;s Registration Statement on Form S-1 (File No. 333-197182) and incorporated herein by reference).</font></a></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.6</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1607678/000119312514329131/d770501dex1023.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Form of Restricted Stock Award Agreement (2014 Equity Incentive Plan) (previously filed on September 2, 2014 as Exhibit 10.23 to the Registrant&#x2019;s Registration Statement on Form S-1/A (File No. 333-197182) and incorporated herein by reference).</font></a></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.7</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1607678/000095017024063533/vktx-ex4_2.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Viking Therapeutics, Inc. 2024 Equity Incentive Plan (previously filed on May 22, 2024 as Exhibit 4.2 to the Registrant&#x2019;s Registration Statement on Form S-8 (File No. 333-279633) and incorporated herein by reference).</font></a></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.8</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1607678/000095017024063533/vktx-ex4_3.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Form of Stock Option Award Agreement under the Viking Therapeutics, Inc. 2024 Equity Incentive Plan (previously filed on May 22, 2024 as Exhibit 4.3 to the Registrant&#x2019;s Registration Statement on Form S-8 (File No. 333-279633) and incorporated herein by reference).</font></a></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.9</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1607678/000095017024063533/vktx-ex4_4.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Form of Restricted Stock Unit Award Agreement under the Viking Therapeutics, Inc. 2024 Equity Incentive Plan (previously filed on May 22, 2024 as Exhibit 4.4 to the Registrant&#x2019;s Registration Statement on Form S-8 (File No. 333-279633) and incorporated herein by reference).</font></a></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">4.10</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1607678/000095017024063533/vktx-ex4_5.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Form of Restricted Stock Award Agreement under the Viking Therapeutics, Inc. 2024 Equity Incentive Plan (previously filed on May 22, 2024 as Exhibit 4.5 to the Registrant&#x2019;s Registration Statement on Form S-8 (File No. 333-279633) and incorporated herein by reference).</font></a></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.1*</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="vktx-ex5_1.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Opinion of Paul Hastings LLP.</font></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.2</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1607678/000119312515166551/d920067dex51.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Opinion of Paul Hastings LLP (previously filed on May 1, 2015 as Exhibit 5.1 to the Registrant&#x2019;s Registration Statement on Form S-8 (File No. 333-203810) and incorporated herein by reference).</font></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.3</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1607678/000156459016018996/vktx-ex51_6.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Opinion of Paul Hastings LLP (previously filed on May 10, 2016 as Exhibit 5.1 to the Registrant&#x2019;s Registration Statement on Form S-8 (File No. 333-211270) and incorporated herein by reference).</font></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.4</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1607678/000156459017004914/vktx-ex51_7.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Opinion of Paul Hastings LLP (previously filed on March 21, 2017 as Exhibit 5.1 to the Registrant&#x2019;s Registration Statement on Form S-8 (File No. 333-216857) and incorporated herein by reference).</font></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.5</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1607678/000156459018004759/vktx-ex51_29.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Opinion of Paul Hastings LLP (previously filed on March 7, 2018 as Exhibit 5.1 to the Registrant&#x2019;s Registration Statement on Form S-8 (File No. 333-223503) and incorporated herein by reference).</font></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.6</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1607678/000156459019007589/vktx-ex51_6.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Opinion of Paul Hastings LLP (previously filed on March 13, 2019 as Exhibit 5.1 to the Registrant&#x2019;s Registration Statement on Form S-8 (File No. 333-230247) and incorporated herein by reference).</font></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.7</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1607678/000156459020006838/vktx-ex51_6.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Opinion of Paul Hastings LLP (previously filed on February 26, 2020 as Exhibit 5.1 to the Registrant&#x2019;s Registration Statement on Form S-8 (File No. 333-236666) and incorporated herein by reference).</font></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
  </table>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:8%;"></td>
    <td style="width:2%;"></td>
    <td style="width:90%;"></td>
   </tr>
   <tr style="height:10pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.8</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1607678/000156459021006421/vktx-ex51_6.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Opinion of Paul Hastings LLP (previously filed on February 17, 2021 as Exhibit 5.1 to the Registrant&#x2019;s Registration Statement on Form S-8 (File No. 333-253219) and incorporated herein by reference).</font></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.9</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1607678/000156459022004440/vktx-ex51_6.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Opinion of Paul Hastings LLP (previously filed on February 9, 2022 as Exhibit 5.1 to the Registrant&#x2019;s Registration Statement on Form S-8 (File No. 333-262609) and incorporated herein by reference).</font></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.10</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1607678/000156459023001696/vktx-ex51_6.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Opinion of Paul Hastings LLP (previously filed on February 10, 2023 as Exhibit 5.1 to the Registrant&#x2019;s Registration Statement on Form S-8 (File No. 333-269675) and incorporated herein by reference).</font></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">5.11</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1607678/000095017024012328/vktx-ex5_1.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Opinion of Paul Hastings LLP (previously filed on February 7, 2024 as Exhibit 5.1 to the Registrant&#x2019;s Registration Statement on Form S-8 (File No. 333-276939) and incorporated herein by reference).</font></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">23.1*</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="vktx-ex23_1.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Consent of Marcum LLP, Independent Registered Public Accounting Firm.</font></a></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">23.2*</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="vktx-ex5_1.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Consent of Paul Hastings LLP is contained in Exhibit 5.1 to this Registration Statement.</font></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">23.3</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">C</font><a href="https://www.sec.gov/Archives/edgar/data/1607678/000119312515166551/d920067dex51.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">onsent of Paul Hastings LLP is contained in Exhibit 5.2 to this Registration Statement.</font></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">23.4</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1607678/000156459016018996/vktx-ex51_6.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Consent of Paul Hastings LLP is contained in Exhibit 5.3 to this Registration Statement.</font></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">23.5</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1607678/000156459017004914/vktx-ex51_7.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Consent of Paul Hastings LLP is contained in Exhibit 5.4 to this Registration Statement.</font></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">23.6</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1607678/000156459018004759/vktx-ex51_29.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Consent of Paul Hastings LLP is contained in Exhibit 5.5 to this Registration Statement.</font></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">23.7</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1607678/000156459019007589/vktx-ex51_6.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Consent of Paul Hastings LLP is contained in Exhibit 5.6 to this Registration Statement.</font></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">23.8</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1607678/000156459020006838/vktx-ex51_6.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Consent of Paul Hastings LLP is contained in Exhibit 5.7 to this Registration Statement.</font></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">23.9</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1607678/000156459021006421/vktx-ex51_6.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Consent of Paul Hastings LLP is contained in Exhibit 5.8 to this Registration Statement.</font></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">23.10</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1607678/000156459022004440/vktx-ex51_6.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Consent of Paul Hastings LLP is contained in Exhibit 5.9 to this Registration Statement.</font></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">23.11</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1607678/000156459023001696/vktx-ex51_6.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Consent of Paul Hastings LLP is contained in Exhibit 5.10 to this Registration Statement.</font></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">23.12</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1607678/000095017024012328/vktx-ex5_1.htm"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Consent of Paul Hastings LLP is contained in Exhibit 5.11 to this Registration Statement.</font></a></p></td>
   </tr>
   <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;background-color:#cceeff;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">24.1*</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="#sig_1"><font style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Power of Attorney is contained on the signature page.</font></a></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">*Filed herewith.</font></p>
  <p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">ITEM 9. UNDERTAKINGS.</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(a) The Registrant hereby undertakes:</font></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:</font></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(i) To include any prospectus required by Section 10(a)(3) of the Securities Act;</font></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(ii) To reflect in the prospectus any facts or events arising after the effective date of this Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in this Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">volume and price represent no more than a 20 percent change in the maximum aggregate offering price set forth in the &#x201c;Calculation of Registration Fee&#x201d; table in the effective registration statement; and</font></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(iii) To include any material information with respect to the plan of distribution not previously disclosed in this Registration Statement or any material change to such information in this Registration Statement;</font></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Provided, however, that:</font></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(A) paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the SEC by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in this Registration Statement.</font></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(2) That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">bona fide</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> offering thereof.</font></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.</font></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(b) The Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant&#x2019;s annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act that is incorporated by reference in this Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">bona fide</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> offering thereof.</font></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(h) Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
  <div style="padding-top:0.5in;min-height:1in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;" id="sig_1"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">SIGNATURES</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of San Diego, State of California, on May 22, 2024.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:45.92%;"></td>
    <td style="width:5.1%;"></td>
    <td style="width:34.7%;"></td>
    <td style="width:14.28%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td colspan="3" style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Viking Therapeutics, Inc.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;border-bottom:3pt solid #ffffff;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;border-bottom:3pt solid #ffffff;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">By:</font><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td colspan="2" style="vertical-align:top;border-bottom:1.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">/s/ Brian Lian, Ph.D.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Name:</font></p></td>
    <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Brian Lian, Ph.D.</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Title:</font></p></td>
    <td colspan="2" style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">President and Chief Executive Officer</font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">POWER OF ATTORNEY</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Know All Persons By These Presents</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, that each person whose signature appears below constitutes and appoints Brian Lian, Ph.D. and Greg Zante, and each or any one of them, as his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or his substitutes or substitute, may lawfully do or cause to be done by virtue hereof.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="text-indent:6.667%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:33.68%;"></td>
    <td style="width:1.02%;"></td>
    <td style="width:41.84%;"></td>
    <td style="width:1.02%;"></td>
    <td style="width:22.44%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;border-bottom:1.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">SIGNATURE</font></p></td>
    <td style="vertical-align:top;border-bottom:1.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;border-bottom:1.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">TITLE</font></p></td>
    <td style="vertical-align:top;border-bottom:1.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;border-bottom:1.5pt solid #000000;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">DATE</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">  </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">  </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">  </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">  </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">  </font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:bottom;border-bottom:1.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">/s/ Brian Lian, Ph.D.</font></p></td>
    <td style="vertical-align:top;border-bottom:1.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Brian Lian, Ph.D.</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">President, Chief Executive Officer and Director</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">May 22, 2024</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">  </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">  </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(Principal Executive Officer)</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:bottom;border-bottom:1.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">/s/ Greg Zante</font></p></td>
    <td style="vertical-align:top;border-bottom:1.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Greg Zante</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Chief Financial Officer</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">May 22, 2024</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">  </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">  </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">(Principal Financial and Accounting Officer)</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:bottom;border-bottom:1.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">/s/ Matthew W. Foehr</font></p></td>
    <td style="vertical-align:top;border-bottom:1.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Matthew W. Foehr</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Director</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">May 22, 2024</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:bottom;border-bottom:1.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">/s/ Lawson Macartney, Ph.D.</font></p></td>
    <td style="vertical-align:top;border-bottom:1.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Lawson Macartney, Ph.D.</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Director</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">May 22, 2024</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;border-bottom:1.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">/s/ Sarah Kathryn Rouan</font></p></td>
    <td style="vertical-align:top;border-bottom:1.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Sarah Kathryn Rouan</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Director</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">May 22, 2024</font></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;border-bottom:1.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">/s/ Charles A. Rowland Jr.</font></p></td>
    <td style="vertical-align:top;border-bottom:1.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Charles A. Rowland Jr.</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Director</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">May 22, 2024</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;border-bottom:1.5pt solid #000000;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">/s/ J. Matthew Singleton</font></p></td>
    <td style="vertical-align:top;border-bottom:1.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
    <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;min-width:fit-content;">&#160;</font></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">J. Matthew Singleton</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Director</font></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;">May 22, 2024</font></p></td>
   </tr>
   <tr style="height:12pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
    <td style="vertical-align:top;"><p style="font-size:12pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </font></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <div style="flex-direction:column;display:flex;padding-bottom:0.5in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p></div>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>vktx-ex5_1.htm
<DESCRIPTION>EX-5.1
<TEXT>
<html>
 <head>
  <title>EX-5.1</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div class="section-group" style="margin:auto;padding-left:1in;width:6.5in;padding-right:1in;"><div class="page" style="flex-direction:column;display:flex;min-height:11in;"><div style="margin-left:-1in;position:relative;"><img src="img246856755_0.jpg" alt="img246856755_0.jpg" style="transform:translate(0px, 0px) rotate(0.0deg);z-index:1;overflow:hidden;top:0.5in;left:0.5in;width:183.3333264089656px;position:absolute;height:53.86666666666667px;"><img src="img246856755_1.jpg" alt="img246856755_1.jpg" style="transform:translate(0px, 0px) rotate(0.0deg);z-index:1;overflow:hidden;top:10.3in;left:3.3in;width:453.06665819338855px;position:absolute;height:29.53333333333333px;"></div><div style="padding-top:1.13in;min-height:2.3in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">Exhibit 5.1</font></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">79891.00006</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">May 22, 2024</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">Viking Therapeutics, Inc.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">9920 Pacific Heights Blvd, Suite 350</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">San Diego, CA 92121</font></p><p style="text-indent:-36pt;padding-left:36pt;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;margin-right:0.07847222222222222in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">Re: Post-Effective Amendment No. 1 to Registration Statements on Form S-8</font></p><p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:12pt;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">Ladies and Gentlemen:</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">We have acted as counsel to Viking Therapeutics, Inc., a Delaware corporation (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-style:italic;min-width:fit-content;">Company</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d;), in connection with the Post-Effective Amendment No 1 to Registration Statements on Form S-8 (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-style:italic;min-width:fit-content;">Post-Effective Amendment</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d;) to be filed by the Company with the U.S. Securities and Exchange Commission (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-style:italic;min-width:fit-content;">Commission</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d;) on or about the date hereof under the Securities Act of 1933, as amended (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-style:italic;min-width:fit-content;">Securities Act</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d;). The Post-Effective Amendment provides for the registration of up to a maximum of 7,674,614 shares (such Shares, the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-style:italic;min-width:fit-content;">Carryover Shares</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d;) of the Company&#x2019;s common stock, $0.00001 par value per share (&#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-style:italic;min-width:fit-content;">Common Stock</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d;), which is a portion of the shares of Common Stock previously registered pursuant to the following registration statements, that may become available for issuance pursuant to the Company&#x2019;s 2024 Equity Incentive Plan (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-style:italic;min-width:fit-content;">2024 Plan</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d;):</font></p><p style="text-indent:-36pt;padding-left:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p><div style="margin-left:0.5in;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.5in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:8.332972223425923%;display:inline-flex;justify-content:flex-start;">(1)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">Registration Statement on Form S-8 (File No. 333-203810) filed on May 1, 2015, with respect to 1,527,770 shares of Common Stock issued or issuable under the Viking Therapeutics, Inc. 2014 Equity Incentive Plan, as amended (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-style:italic;min-width:fit-content;">2014 Plan</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d;);</font></div></div><p style="text-indent:-36pt;padding-left:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p><div style="margin-left:0.5in;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.5in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:8.332972223425923%;display:inline-flex;justify-content:flex-start;">(2)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">Registration Statement on Form S-8 (File No. 333-211270) filed on May 10, 2016, with respect to 338,930 shares of Common Stock issued or issuable under the 2014 Plan;</font></div></div><p style="text-indent:-36pt;padding-left:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p><div style="margin-left:0.5in;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.5in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:8.332972223425923%;display:inline-flex;justify-content:flex-start;">(3)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">Registration Statement on Form S-8 (File No. 333-216857) filed on March 21, 2017, with respect to 728,835 shares of Common Stock issued or issuable under the 2014 Plan;</font></div></div><p style="text-indent:-36pt;padding-left:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p><div style="margin-left:0.5in;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.5in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:8.332972223425923%;display:inline-flex;justify-content:flex-start;">(4)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">Registration Statement on Form S-8 (File No. 333-223503) filed on March 7, 2018, with respect to 1,253,598 shares of Common Stock issued or issuable under the 2014 Plan;</font></div></div><p style="text-indent:-36pt;padding-left:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p><div style="margin-left:0.5in;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.5in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:8.332972223425923%;display:inline-flex;justify-content:flex-start;">(5)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">Registration Statement on Form S-8 (File No. 333-230247) filed on March 13, 2019, with respect to 2,510,971 shares of Common Stock issued or issuable under the 2014 Plan;</font></div></div><p style="text-indent:-36pt;padding-left:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p><div style="margin-left:0.5in;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.5in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:8.332972223425923%;display:inline-flex;justify-content:flex-start;">(6)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">Registration Statement on Form S-8 (File No. 333-236666) filed on February 26, 2020, with respect to 2,534,476 shares of Common Stock issued or issuable under the 2014 Plan;</font></div></div><p style="text-indent:-36pt;padding-left:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p><div style="margin-left:0.5in;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.5in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:8.332972223425923%;display:inline-flex;justify-content:flex-start;">(7)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">Registration Statement on Form S-8 (File No. 333-253219) filed on February 17, 2021, with respect to 2,562,557 shares of Common Stock issued or issuable under the 2014 Plan;</font></div></div><p style="text-indent:-36pt;padding-left:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p><div style="margin-left:0.5in;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.5in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:8.332972223425923%;display:inline-flex;justify-content:flex-start;">(8)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">Registration Statement on Form S-8 (File No. 333-262609) filed on February 9, 2022, with respect to 2,738,694 shares of Common Stock issued or issuable under the 2014 Plan;</font></div></div><p style="text-indent:-36pt;padding-left:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><div style="flex-grow:1;"></div><div style="flex-direction:column;display:flex;padding-bottom:0.25in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;">&#160;</p></div></div>
   <hr style="page-break-after:always;"><div class="page" style="flex-direction:column;display:flex;min-height:11in;"><div style="margin-left:-1in;position:relative;"><img src="img246856755_2.jpg" alt="img246856755_2.jpg" style="transform:translate(0px, 0px) rotate(0.0deg);z-index:1;overflow:hidden;top:0.5in;left:0.5in;width:144px;position:absolute;height:42.33333333333333px;"></div><div style="padding-top:1.13in;min-height:2.3in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">Viking Therapeutics, Inc.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:24pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">May 22, 2024<br>Page </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">2</font></p></div><div style="margin-left:0.5in;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.5in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:8.332972223425923%;display:inline-flex;justify-content:flex-start;">(9)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">Registration Statement on Form S-8 (File No. 333-269675) filed on February 10, 2023, with respect to 2,739,004 shares of Common Stock issued or issuable under the 2014 Plan; and</font></div></div><p style="text-indent:-36pt;padding-left:36pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p><div style="margin-left:0.5in;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.5in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:8.332972223425923%;display:inline-flex;justify-content:flex-start;">(10)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">Registration Statement on Form S-8 (File No. 333-276939) filed on February 7, 2024, with respect to 3,503,981 shares of Common Stock issued or issuable under the 2014 Plan (the registration statements listed in (1) through (10) are referred to herein as the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-style:italic;min-width:fit-content;">Registration Statements</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d;).</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">The Carryover Shares will become available for issuance pursuant to the 2024 Plan to the extent that any such Carryover Shares are subject to awards previously granted under the 2014 Plan and, after the date hereof, any such equity award terminates or expires prior to exercise or settlement, is not issued because the award is settled in cash, is forfeited because of the failure to vest or is reacquired or withheld (or not issued) to satisfy a tax withholding obligation or the purchase or exercise price.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">As such counsel and for purposes of our opinion set forth below, we have examined and relied upon originals or copies, certified or otherwise identified to our satisfaction, of such documents, resolutions, certificates and instruments of the Company and corporate records furnished to us by the Company, and have reviewed certificates of public officials, statutes, records and such other instruments and documents as we have deemed necessary or appropriate as a basis for the opinion set forth below, including, without limitation:</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p><div style="margin-left:0.8395833333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:6.01150626413881%;display:inline-flex;justify-content:flex-start;">(i)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">the Post-Effective Amendment;</font></div></div><div style="margin-left:0.8395833333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:6.01150626413881%;display:inline-flex;justify-content:flex-start;">(ii)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">the Registration Statements</font></div></div><div style="margin-left:0.8395833333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:6.01150626413881%;display:inline-flex;justify-content:flex-start;">(iii)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">the Amended and Restated Certificate of Incorporation of the Company, certified by the Office of the Secretary of State of the State of Delaware on May 21, 2024;</font></div></div><div style="margin-left:0.8395833333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:6.01150626413881%;display:inline-flex;justify-content:flex-start;">(iv)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">the Amended and Restated Bylaws of the Company, as presently in effect, as certified by an officer of the Company on May 22, 2024;</font></div></div><div style="margin-left:0.8395833333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:6.01150626413881%;display:inline-flex;justify-content:flex-start;">(v)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">the 2014 Plan and the forms of award agreements related thereto;</font></div></div><div style="margin-left:0.8395833333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:6.01150626413881%;display:inline-flex;justify-content:flex-start;">(vi)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">the 2024 Plan and the forms of award agreements related thereto;</font></div></div><div style="margin-left:0.8395833333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:6.01150626413881%;display:inline-flex;justify-content:flex-start;">(vii)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">a certificate, dated as of May 21, 2024, from the Office of the Secretary of State of the State of Delaware, as to the existence and good standing of the Company in the State of Delaware (the &#x201c;</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-style:italic;min-width:fit-content;">Good Standing Certificate</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201d;); and</font></div></div><div style="margin-left:0.8395833333333335in;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:0.3402777777777778in;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:6.01150626413881%;display:inline-flex;justify-content:flex-start;">(viii)</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">the resolutions adopted by the board of directors of the Company regarding the 2024 Plan and other matters related thereto, as certified by an officer of the Company on May 22, 2024.</font></div></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">In addition to the foregoing, we have made such investigations of law as we have deemed necessary or appropriate as a basis for the opinion set forth in this opinion letter.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">In such examination and in rendering the opinion expressed below, we have assumed, without independent investigation or verification: (i) the genuineness of all signatures on all agreements, instruments, corporate records, certificates and other documents submitted to us; (ii) the authenticity and completeness of all agreements, instruments, corporate records, certificates and other documents submitted to us as originals;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;"> </font></p><div style="flex-grow:1;"></div><div style="flex-direction:column;display:flex;padding-bottom:0.25in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></div></div>
   <hr style="page-break-after:always;"><div class="page" style="flex-direction:column;display:flex;min-height:11in;"><div style="margin-left:-1in;position:relative;"><img src="img246856755_2.jpg" alt="img246856755_2.jpg" style="transform:translate(0px, 0px) rotate(0.0deg);z-index:1;overflow:hidden;top:0.5in;left:0.5in;width:144px;position:absolute;height:42.33333333333333px;"></div><div style="padding-top:1.13in;min-height:2.3in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">Viking Therapeutics, Inc.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:24pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">May 22, 2024<br>Page </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">3</font></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">(iii) that all agreements, instruments, corporate records, certificates and other documents submitted to us as certified, electronic, facsimile, conformed, photostatic or other copies conform to originals thereof, and that such originals are authentic and complete; (iv) the legal capacity and authority of all persons or entities (other than the Company) executing all agreements, instruments, corporate records, certificates and other documents submitted to us; (v) the due authorization, execution and delivery of all agreements, instruments, corporate records, certificates and other documents by all parties thereto (other than the Company); (vi) that no documents submitted to us have been amended or terminated orally or in writing except as has been disclosed to us in writing; (vii) that the statements contained in the certificates and comparable documents of public officials, officers and representatives of the Company and other persons on which we have relied for the purposes of this opinion letter are true and correct; (viii) that there has not been any change in the good standing status of the Company from that reported in the Good Standing Certificate; and (ix) that each of the officers and directors of the Company has properly exercised his or her fiduciary duties. As to all questions of fact material to this opinion letter, and as to the materiality of any fact or other matter referred to herein, we have relied (without independent investigation or verification) upon representations and certificates or comparable documents of officers and representatives of the Company. Our knowledge of the Company and its legal and other affairs is limited by the scope of our engagement, which scope includes the delivery of this opinion letter. We do not represent the Company with respect to all legal matters or issues.  The Company may employ other independent counsel and, to our knowledge, handles certain legal matters and issues without the assistance of independent counsel. We have also assumed that the individual issuances, grants, awards or grants of purchase rights under the 2024 Plan will be duly authorized by all necessary corporate action of the Company and duly issued, granted or awarded and exercised in accordance with the requirements of law, the 2024 Plan and the agreements, forms of instrument, awards and grants duly adopted thereunder.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">Based upon the foregoing, and in reliance thereon, and subject to the assumptions, limitations, qualifications and exceptions set forth herein, we are of the opinion that the Carryover Shares are duly authorized and, when issued and sold as described in the Registration Statements, as amended by the Post-Effective Amendment, and in accordance with the 2024 Plan and the applicable award agreements or forms of instrument evidencing purchase rights thereunder (including the receipt by the Company of the full consideration therefor), will be validly issued, fully paid and nonassessable.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">Without limiting any of the other limitations, exceptions and qualifications stated elsewhere herein, we express no opinion with regard to the applicability or effect of the laws of any jurisdiction other than the General Corporation Law of the State of Delaware, as in effect on the date of this opinion letter.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">This opinion letter deals only with the specified legal issues expressly addressed herein, and you should not infer any opinion that is not explicitly stated herein from any matter addressed in this opinion letter.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">This opinion letter is rendered solely in connection with the issuance and delivery of the Carryover Shares as described in the Post-Effective Amendment and in accordance with the terms of the 2024 Plan and the applicable award agreement or form of instrument evidencing purchase rights thereunder. This opinion letter is rendered as of the date hereof, and we assume no obligation to advise you or any other person with regard to any change after the date hereof in the circumstances or the law that may bear on the matters set forth herein even if the change may affect the legal analysis or a legal conclusion or other matters in this opinion letter.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p><div style="flex-grow:1;"></div><div style="flex-direction:column;display:flex;padding-bottom:0.25in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></div></div>
   <hr style="page-break-after:always;"><div class="page" style="flex-direction:column;display:flex;min-height:11in;"><div style="margin-left:-1in;position:relative;"><img src="img246856755_2.jpg" alt="img246856755_2.jpg" style="transform:translate(0px, 0px) rotate(0.0deg);z-index:1;overflow:hidden;top:0.5in;left:0.5in;width:144px;position:absolute;height:42.33333333333333px;"></div><div style="padding-top:1.13in;min-height:2.3in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">Viking Therapeutics, Inc.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:24pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">May 22, 2024<br>Page </font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">4</font></p></div><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">We hereby consent to the filing of this opinion letter as Exhibit 5.1 to the Post-Effective Amendment. In giving such consent, we do not hereby admit that we are within the category of persons whose consent is required under Section 7 of the Securities Act or the rules or regulations of the Commission thereunder.</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">Very truly yours,</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">/s/ Paul Hastings LLP</font></p><div style="flex-grow:1;"></div><div style="flex-direction:column;display:flex;padding-bottom:0.25in;min-height:1in;justify-content:flex-end;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p></div></div>
   <hr style="page-break-after:always;"></div>
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>vktx-ex23_1.htm
<DESCRIPTION>EX-23.1
<TEXT>
<html>
 <head>
  <title>EX-23.1</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div style="padding-top:0.5in;min-height:0.5in;box-sizing:border-box;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Exhibit 23.1</font></p></div>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="text-transform:uppercase;color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Independent Registered Public Accounting Firm&#x2019;s Consent</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">We consent to the incorporation by reference in this Registration Statement of Viking Therapeutics, Inc. on the Post-Effective Amendment #1 to Form S-8 (File Nos. 333-203810, 333-211270, 333-216857, 333-223503, 333-230247, 333-236666, 333-253219, 333-262609, 333-269675 and 333-276939) of our report dated February 7, 2024, with respect to our audits of the consolidated financial statements of Viking Therapeutics, Inc. as of December 31, 2023 and 2022 and for the years ended December 31, 2023 and 2022 and our report dated February 7, 2024 with respect to our audit of internal control over financial reporting of Viking Therapeutics, Inc. as of December 31, 2023 appearing in the Annual Report on Form 10-K of Viking Therapeutics, Inc. for the year ended December 31, 2023.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">/s/ Marcum </font><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">llp</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Marcum </font><font style="font-variant:small-caps;color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">llp</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Costa Mesa, California</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">May 22, 2024</font></p>
  <div style="flex-direction:column;display:flex;min-height:0.5in;justify-content:flex-end;"></div>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>img246856755_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img246856755_0.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "= A8# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MVZBA_#0\S_WJ7R_(****V. **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJQ_(&K-,336X4444""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Y0_X07Q7_ -"]J/\
MX#M7U5:J4M(58$,(U!![<5+165.DJ=[';B\;+$VYE:P4445J<04444 %9^N7
MMSI^AWEU96LEU=1Q$PPQJ6+OT48';)&?;-:%%#'%V=V?+ \"^+[^_!FT6_\
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M1/GDK!1115G.%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^%E:C_T3[Q7_ . J_P#Q5 'H%%>?_P#"RM1_Z)]XK_\  5?_ (JC_A96H_\
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M"K_\50!Z!17G_P#PLK4?^B?>*_\ P%7_ .*H_P"%E:C_ -$^\5_^ J__ !5
M'H%%>?\ _"RM1_Z)]XK_ / 5?_BJ/^%E:C_T3[Q7_P" J_\ Q5 'H%%>?_\
M"RM1_P"B?>*__ 5?_BJ/^%E:C_T3[Q7_ . J_P#Q5 'H%%>?_P#"RM1_Z)]X
MK_\  5?_ (JC_A96H_\ 1/O%?_@*O_Q5 'H%%>?_ /"RM1_Z)]XK_P# 5?\
MXJC_ (65J/\ T3[Q7_X"K_\ %4 >@45Y_P#\+*U'_HGWBO\ \!5_^*H_X65J
M/_1/O%?_ ("K_P#%4 >@45Y__P +*U'_ *)]XK_\!5_^*H_X65J/_1/O%?\
MX"K_ /%4 >@45Y__ ,+*U'_HGWBO_P !5_\ BJ/^%E:C_P!$^\5_^ J__%4
M>@45Y_\ \+*U'_HGWBO_ ,!5_P#BJ* /0**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** /.?^%N6'_0+N?^_BUZ)&_F1(X&
M P!Q7S%7TU;?\>L/^XO\J ):*** "L?Q+X@B\-Z6+Z:!YE,@CVH0#R"<\_2M
MBN(^*G_(HI_U])_)J )_#OQ M?$6K+I\5C-"Y1GWNP(XKL*\2^&/_(Y1_P#7
M"3^5>VT %%%% !1145U<Q6=I-=3MMBA0N[>@ R: .8\3>/++PUJ"64EM)<2F
M,.WEL!LST!SWJMH?Q(L-:U>'3_LDUNTV0CNP(SC('XUY/?W=UXC\023[2UQ>
M3 (@.<9.%7\.!4%Q!=:-JSPN3'=6DV,CLRG@C\LTP/I2BL[0=5CUO1+34(\#
MSD!=1_"PX8?F#6C2 **** "HY[B&U@>>XE2*)!EG=L!1[FI*\8^(_B6;4M9D
MTN&0BRM&VLH/WY!U)^G3\#0!U&J_%73+5VCTZUEO6''F$^6A^F02?R%8+?%O
M5"QV:=9A>P)8G^=9WA/P#=>(H1>W$WV6QSA6VY>3'7:/3WKNH_A=X=1 K"[D
M/]YIN3^0% '-V_Q=O5?_ $G2[>1?^F<C(?US76:'\0M$UJ1(&=K.Y;@1SX 8
M^@;I^>*R[[X3Z5+&QLKRYMY.V\AU_+ /ZUYKK_A^^\.7_P!EO47YANCD0Y5Q
MZC_"@#Z*HKS_ .&?B>;4K632;V0R3VR[XG8Y+1],'Z$C\#[5Z!0 5P6H?%&R
MT_4KJR?3;AVMYGB+!Q@E21G]*[VO/M1^%L.H:I=WIU61#<3/*4$ .W<Q.,Y]
MZ (O^%N6'_0+N?\ OXM'_"W+#_H%W/\ W\6HO^%0P?\ 09D_[\#_ .*K(\3_
M  [B\/:%-J*:D\YC91L,07.2!US[T ;G_"W+#_H%W/\ W\6C_A;EA_T"[G_O
MXM>=^&]'77M?MM,:8PB;?^\"[L84MT_"N_\ ^%0P?]!F3_OP/_BJ )?^%N6'
M_0+N?^_BUUWAKQ!%XDTLWT,#PJ)#'M<@G@ YX^M<9_PJ&#_H,R?]^!_\578^
M&/#Z>&M*-@EPUP#*9-Y3;U &,9/I0!M4444 <)J?Q.L],U2ZL7TZ=VMY&C+*
MXP<'&:ZS1=436M'M]1CC:-)P2$8Y(P2/Z5X1XL_Y&[5O^OJ3^=>Q^ _^1(TS
M_<;_ -#:@#HZ*** *6KZBFD:3<ZA)&TB0)O**<$UPW_"W+#_ *!=S_W\6NH\
M:?\ (FZK_P!<#_,5\_4 ?2>E:I:ZSIL-]9ONAE&1GJI[@^A%7*\)\$^+)/#>
MI;)BS:?.0)D'.P_WQ[COZC\*]SBECGB26)U>-U#*RG((/0B@!]%%% ')^)_'
M5MX8U*.RFLI9V>$2AD8  $D8Y_W:O>%_%$/BBVN)H;:2 0N$(=@<Y&>U>=?%
MG_D:K7_KR3_T-ZW?A'_R"M2_Z[K_ .@T >C4444 %%%>>_$'QM)I9.D:7+MN
MV7,\R]8@>@'^T1W[#WZ '1:[XST;0"8[FX\RX'_+" ;G'U[#\37%W?Q=G+D6
M6E1JO9II"Q/X#&/SKA]'T34?$6H&WLHS)(?FDD<_*@/=C_DFO2-.^$UA%&&U
M&^GGD[K#A%'MSDG]* ,4?%O5LC.GV6/^!_XUJ6/Q<@9@NH:7)&.[P2!O_'3C
M^=:[?"_PX5("72GU$W_UJY[6?A.\432Z->-*0,^1<8#'Z,,#/U ^M 'H6D:]
MIFNP&73KI)MOWDZ,OU!Y%:5?-EM=7VB:F)87DMKN!\$8P01U!']#7N_A3Q%%
MXET9+L ).AV3QC^%O;V/4?\ UJ -RBBB@ JKJ&I6>E6;75]<)!"O5F/4^@'4
MGV%6B0 23@#O7S]XM\1S^(]9DF+M]DC)6WC[*OKCU/4__6H [G4?BW:QNR:=
MITDX' DF?8/R&3_*LD_%O5LG&GV6/^!_XTGAGX9S:I:1WNJSO;02 ,D,8'F,
MOJ2>%_(UUB_##PX% *73'U,W_P!:@#G;7XNW 8"\TF-U[F&4J1^!!KM=!\9Z
M/XA816LYCN<9\B8;7/T['\#7,:G\);-XF;2[^:.4#A+C#*3]0 1^M>9WME>Z
M)J;V]PKV]U P.0<$'J""/S!H ^DZ*Y?P+XC?Q%H6ZX(-Y;-Y<Q_O>C?C_,&B
M@#PBOIJV_P"/6'_<7^5?,M=@GQ,\1HBHLMMA1@?N13$>WT5XE_PL[Q)_SUMO
M^_(H_P"%G>)/^>MM_P!^12&>VUQ'Q4_Y%%/^OI/Y-7$_\+.\2?\ /6V_[\BL
M[6O&>L:_8BSOGA,(</A(]IR,_P"- &C\,?\ D<H_^N$G\J]MKQ+X8_\ (Y1_
M]<)/Y5[;0 4444 %>?\ Q3UO[)I,6DQ/B6[.Z3':,'^I_D:[]F5%+,0% R2>
MPKYY\4:RVO>(;J^R?*+;(0>R#@?GU^I- '1_"[1OMVO2:C(N8;)?ESWD;@?D
M,G\JL_%71?L^I6^L1+B.Y'E2X'\8'!_%?_0:[KP5HO\ 8?ABV@==L\H\Z;(Y
MW-V_ 8'X5:\3Z.-=\/7=C@>8R[HB>SCD?X?C0!P'PHUOR[FXT65OEE_?09_O
M ?,/Q !_ UZM7S787L^DZI!>196:WD# 'U!Y!_E7T987L.HZ?;WMN<Q3QB1?
MH1W]Z +%%%% !7S=K(D&NZ@)?]8+F3?]=QS7TC7E/Q"\%W1OY=:TV%IHI?FN
M(D&61N[ =P>_ISVZ '<^#;NVN_".FFU=2(H$BD _A=0 P/X\_C6[7S;IVK:A
MI$YEL+N6W<]=C<-]1T/XUU%I\4?$,&!-]EN1W,D6#_XZ10![57.^,?#'_"4:
M7%;I(D,\4N])'&<#&"/QX_*N3M?B\O O-((]6AFS^A']:Z'3?B/X=U!@CW$E
MFYZ"Y3:/^^AD#\2* ,SPK\/[[P[KT.H/J$$L:JRNBJ06!'^.*] IJ.DL:R1N
MKHPRK*<@CVIU !1110 5R7Q)_P"1)N_]^/\ ]#%=;7)?$G_D2;O_ 'X__0Q0
M!YK\._\ D>]-_P"VO_HIZ]WKPCX=_P#(]Z;_ -M?_13U[O0 4444 %%%% 'S
MSXL_Y&[5O^OJ3^=>Q^ _^1(TS_<;_P!#:O'/%G_(W:M_U]2?SKV/P'_R)&F?
M[C?^AM0!T=%%% &#XT_Y$W5?^N!_F*\4\+Q1S^*-,BE17C>X165AD$$\@U[7
MXT_Y$W5?^N!_F*\7\)_\C=I/_7U'_.F!H>-O"<GAO4M\(9M/G),+GG8?[A]Q
MV]1^-;GPY\8_8IDT34)?]'D.+>1C_JV/\)]C^A^M>G:KI=KK.FS6-XFZ&48.
M.JGL1Z$5X!X@T*Z\/:M)8W(SCYHY ,"1.S#_ #UH ^BZ*X/X>^,?[6METJ_E
MS?0K^[=CS,@_FP_4<^M=Y2 \<^+/_(U6O_7DG_H;UN_"/_D%:E_UW7_T&L+X
ML_\ (U6O_7DG_H;UN_"/_D%:E_UW7_T&F!Z-1112 JZG?)IFEW5](,K!$TA'
MK@=/QKYSDDN=4U%I&S+=7,N3ZLS'_$U[5\2)S!X)NU7K*\:9_P"! _TKR_P'
M;+=>-=-1AE5=I.G0JI8?J!0![+X;T&W\.Z-#90A3)C=-(!R[]S_0>U:]%% !
M15#6-9LM"LA=W\C1PEPF0I;DY[#Z5@_\+)\,?\_LG_?A_P#"@#*^(7@RZUFY
MM]0TFU$MT?DG4.J;A_"W) XY'Y>E5_A_X>\1>']:E-]8F*RGB*N?.1@&'*G
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M]12 ^:W2]T352K;[:]M9/H585[EX/\4P^)M+#G:E[#A9XAZ_WA[&LOQ_X/\
M[<M/[0LHQ_:$"\J/^6R#M]1V_*O)]%UB[T#58[ZU.)$.'0]'7NII@=7\6?\
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MIZ8HKSX*6. "3[44Q"5]-6W_ !ZP_P"XO\J\^_X5'8?]!2Y_[]K7HD:>7$B
MY"@#-(8ZBBB@ KB/BI_R**?]?2?R:NWK'\2^'XO$FEBQFG>%1()-R $\ C'/
MUH \J^&/_(Y1_P#7"3^5>VUQ_AWX?VOAW5EU"*^FF<(R;'4 <UV% !7.^-M;
M_L+PS<3(VVXF_<PXZ[CW_ 9/X"NBKFO%/@^/Q3-;M/?S0QP*0L:*",GJ>?H/
MRH \6T'2I-;URTT^/(\YP'8?PJ.6/X &OHN**."%(8E"1QJ%51T ' %<QX8\
M#67AF]ENXKB2XE=/+!D4#:,Y.,>N!754 %%%% "$!@00"#P0:^>_%>C'0?$=
MU9!2(=V^$GNAY'Y=/PKZ%KFO%/@RS\426\LT\D$L(*[XP#N4]CGT_J: ,WX9
M:W_:/A\V$K9GL2%&>IC/W?RY'X"NWKD/#G@.'PWJHOK?49Y,H4>-D # _P#U
MP#^%=?0 5X5XW\*S>']5DFAC8Z=.Q:)P.$)YV'TQV]1^->ZU'/!#=0/!<1)+
M$XPR.H(8>X- 'AWACQWJ/AR,6Q5;JRSD0N<%/7:W;Z<BN[MOBMH4JCSX+R!N
M^4##\P<_I2:I\*](O':2QGFL6/\ "/WB#Z \_K7GVJ^%?[,G\O[;YG)&?*Q_
M6@#T2X^*F@1)F*.\F;L%C _F:X7Q5X\OO$<7V2.(6EEG)C5LM)Z;CZ>W\ZK:
M1X3_ +5N1#]M\K)QGRMW]17H>D_"[1K&19;V26^=?X7^2/\ [Y'/YF@#D_AO
MX8FO]6CU>XC*V=JVZ,L/]9)VQ[#KGU ]Z]DIL<:0QK'&BHBC"JHP /0"G4 %
M%%% !7)?$G_D2;O_ 'X__0Q76UE^(-%C\0:/+ITLS1)(5)=1DC!S_2@#QSX=
M_P#(]Z;_ -M?_13U[O7%Z#\.K30=:M]2BOYY7AW81D !RI7^M=I0 4444 %%
M%% 'SSXL_P"1NU;_ *^I/YU['X#_ .1(TS_<;_T-JQ]3^&-GJ>J75\^HSHUQ
M(TA54&!DYQ76:+I::+H]OIT<C2) " [#!.23_6@"_1110!@^-/\ D3=5_P"N
M!_F*\7\)_P#(W:3_ -?4?\Z]YU?3DU?2;G3Y)&C2=-A=1DBN1TSX8V>F:I:W
MR:C.[6\BR!608.#G% '=T444 %>5_$?P=Y32:[IT?R,<W42C[I_OCV]?S]:]
M4IKHLB,CJ&1AAE89!'H: /F*O6?A'_R"M2_Z[K_Z#4US\)],FNI98;ZXAC=B
MRQ!00@] 3VKHO"_A>'PO;7$,-S).)G#DNH&,#':@#>HHHH *\X^(?@J6^=M9
MTN(O/C_2(5ZN!_$H]<=1W_GZ/10!\YZ+KVH^'KTW%A,48\21L,JX'9A_DUZ-
MI_Q:LG0#4=/GB?\ O0$.I_ D$?K71ZYX(T37G::>W,-RW6> [6/U['\1FO//
M$'P]31LO'J32(5W!6AP1^.[^E '9/\4?#JIN!NW/]U8>?U.*YW6?BQ/-$T6D
M6?D$\>?.0S#Z*. ?J37'VV@_:)Q']IVYSSY>?ZUZ%I'PKTU!'/?WDUV" WEJ
MOEK]#R3^1% '!:-H.K>+;^>5"\F,O/<R<\XSCW)]*B\)_P#(W:3_ -?4?\Z]
M_M+.VL+9+:T@2&%!A408 KCK'X:65AK4.I1WTY,4PF6,H,<'.* .XHHHH AO
M+6&^LYK2X7=#,A1QZ@C%?/GB+P_>>'=3>TN4)0DF*7'RR+ZCW]1VKZ)JKJ&F
MV6JVK6U];1SPM_"XZ'U!Z@^XH \C\.?$J_TBWCM+Z'[;;H-J-NVR*/3/<?7\
MZZ^'XI^'Y%S(EY$<<AH@?Y$U1U3X4:<PDFL;^>V !;9(@D'T'(/YYK@;WP]]
MCN#%]JWX[^7C^M,#T>[^*VB1(?LUM=W#]@5"+^9.?TKSOQ-XMO\ Q/.IN-L5
MM&<QP(> ?4GN?>K^A>"/[:E5#J'D@Y_Y8[O_ &85Z'HOPZT32)%FD1[V=3D-
J/C:#[*./SS2 Y_X<>$/W,NJZG;_),FR"*1>JY!+D?@,?C[45Z=10!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>img246856755_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img246856755_1.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !<!8,# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHC3C:"+YU&<L%+ @XQ@]1Z4 >P23PQ21I)*B/(<(K, 6/MZU)7 >._\ D>/
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M>_) ZUTU<=X?_P"2F>,_^N5A_P"BY* .QHHHH S]7UNPT.V6XU"21(V;8#'
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M4XXZ#V_  ]=HJKIDSW&DV<\K;I)($=CZDJ":?>7<%A93WES(([>"-I)'/15
MR3^5 '&^-]:UU]5L_#GA6X6'59()+R:5HU<)$H(52&! WO@9[5M^#?$*^*/"
MUGJ>-D[+LN(\8V2KPPQVYY^A%<'X(\9:$+G5O$>LW_DZEJL^5A,,C&"W3B-,
MA2.G)P>>*=X4\1Z5I_Q0U'3=-N_-TK7/]*A_=L@CNOXU^8#[P!/_ 'R* /5(
M[B&9Y$BFC=XSAU5@2I]#Z4LLL<,;22R+'&HRS.< ?4UPFI)_PBOQ.LM77"Z?
MX@46-UZ+<KS$Q^H^7\ZE\>EM<U#2/!L#'&H2_:+XJ?NVL9R1[;FP ?:@#M)+
MF"*W-Q)-&D &XRLX"X]<],57L]7TS4)#'9:C:7+J,E89U<@?0&O-=;U'3=1^
M)-YIVNVUW<Z1HL,(M[&WM'FB>5T#;W5 1P#@ \>G>E\2W'A6_P!*EDTK1M1L
M=8@0R65U:Z/-"Z2@?*-P0<'H0>,&@#U*2>&*2-))41Y#A%9@"Q]O6J;Z[H\=
MR;9]5L5G!VF)KA P/IC.<UYGXI:X\2R?#DWXGL[B\E<7(0&-U)1=X'=<\CU&
M:[V;P1X8GTQM/;0K!;=E*X2!0P]PV,@^^<T ;DLT4$32S2)'&O5W8 #\33E8
M,H92"I&01WKQB*\GN_V=-12XE>5K4M;J[G)*K,NW\@0/PKUK1?\ D!:?_P!>
MT?\ Z"* +2SPM.\"RH94 +1AAN4'U%0WFIV&G!3?7UM:A_NF>54S],FN$L+@
M6GQ<\87)7<(=-@DQZX0&L'P?JGA^YL?[<\1:=?:GK=\QDEG?2I9TC7)VI&=I
M4*!CI0!Z[:W=M>PB:TN(KB(G >)PZ_F*FKR@7^GV/C;1[WPKI>HVL=W.+;4K
M<:=+#"Z-PLA!4*"IYS[_ %KU>@ KF?&>I7FF1:$;.<Q&XUFUMI< '=&[$,O/
MK735QWQ"_P!3X:_[&&R_]#- '8T444 97B>\GT[PGK-[:R>7<6]C/-$^ =KJ
MA(.#P>0.M<CX>T_QEKGAW3]4;QU+"UW DQC&EVY"Y&<9QS73^-/^1%\0_P#8
M,N?_ $4U<?X.U/QG%X-T=++P[I\]JMI&(I7U#8SKC@D;>/I0!9UR;QGX,TU]
M;?7(->LK<AKJUGLT@?9D E&3N,]Q^?2NZM[ZWN-.AOUD"VTL2S!W.W"D9!/I
MP:XC6-)\:>,;$Z3J,6FZ-IDQ'VIH9VGGD4'.U?E"@''?_P"L9_%^GZ!;R:$F
MMZM%;:-99"Z4Z%_M;!0$R <L%]-ISWZT =3;Z]H]Y,L-MJMC/*W1(KA&8_@#
M6!\1=;U'0M%L+C3;CR)9=2@@=MBME&SD?,#Z=>M<SXNE\,ZAX2U+^SO"MYYD
M-L\L%W%I36RPLH+!P[*N ,9..O3O1XRN9KWX6^$+NYD,D\]QI\DCMU9F3))_
M$T >INZQH7=@JJ,EF. !5*VUS2+R<06NJ64\QZ1Q7",Q_ &N.UBV_P"$N^)(
MT&_+'1M,LUNY;8,0MS,S87?CJH';U^M;^I^!_#FIZ>UH^D6D&!B*:VA6.2$]
MBC*,@@\T =#17(?#C5KW4_#,D.HS&>\TZ[EL))SUE\LC#'U.".?:NOH Y7QS
MKE]IEE8Z=H\@36=5N5MK5BH;RQG+R$'@A5_F*9X"U^^U?3KRPUE@VM:7<M;7
M9"A=_)VN . "/Y&N2TSQEH6H?$/4]?U/4!';62&QTQ/*=P1G]Y*"JD<G@'T/
MM45]XNT/3OB?IVN:7?\ F6FIQ_8M27RG0*1CRY"6 ]@3V"GUH [#QEK>HZ3K
M7A6WLKCRHK[4E@N5V*V]...0<?48-+KWC./2?%F@:3%+9/!?R3I=2/)\T&Q0
M1WP,DD<^E9WQ#_Y&/P1_V%U_I6?XST#1O^%E>#%_LFPVWLUXUT/LR8G.Q3E^
M/F.23SGDT >F1313Q++#(DD;='1@0?Q%46U_1EN#;MJU@)@=IC-RF[/IC.<U
MR7C.'-YX9\&::!IUAJLTWG_9 (\0Q*'=%QTW9/3^IKH5\%^&%L/L(T#3OL^W
M;M-NI/USC.??.: -VBN$\#O/I'B3Q!X1:XDGL].,4UBTK%FCBD7/EDGLIP!7
M=T %<?X@\3ZB_B&/POX:B@DU5HO.N;FXR8K2/L2!U8]A[CUKL*\^\"8_X3SQ
MWY__ !^?;8LY_P">6UMF/P_I0!HCPEX@91)-XYU,W0'WH[>%8\_[FT\?C4&E
M>(M:TGQ7!X8\3F"X>[C9[#4H$\L3[1EE=.BMCTXZ>M=O5.\U6PL+JTM;JZ2*
M>\<I;QMUD8=0/S% $MW?6EA%YMY=06T><;YI @S]34=GJFGZCN^PWUK=;?O>
M1,KX^N#7#ZDOA:T\:WUYXAU"+5KZ1$2TT[[&UP;- .0$7=RQP<D#]:QO$-SI
M\7B3PMJ.C:!?:5<-K$-K+=O9?95ECD)#1E3@MG!/(X /J* .MO=;U&+XK:;H
MJ7&-/FTV2>2'8O+AB =V,]NF<5I:5-?6MUJ\NKZS9SVOVK_1E4JOV:/LCG Y
M^N:YW4?^2Y:-_P!@B7_T-JK^";"SU+6?'-M?6D%U;MK!+13QAT.,D9!XH F\
M,:WJGBC6;V[;Q'!:6EOJ,EM!IL,43&:-#U9FRWS?[..E=Q>:C8Z<JM>WEO;*
MQPIFE5 ?IDUYW\.],TBSTG7=5.DV37-EJMYY4H@02(B]%5L948R,#UJWX!\/
MVFM:/'XJUV"'4=6U,F8O<()%@3<=J1ALA0!Z<\T =W:7UI?Q>;9W4%S'G&^&
M0.,_45)YT7G^1YJ>=MW^7N&[;G&<=<9[UYUXWTNT\&K:^+="A2PFM[B..\AM
MUV1W,+-M(9!P2,\'_P"M5?Q%IC:S\:K?3VN98+6?0<70B8JTL0G8E PY )"Y
MQVR.] 'HPU/3SYF+ZV/E,%D_>K\A/0'G@\&H[K6M*L9_(N]3L[>7&?+EG5&_
M(FO._B=X?TO0_AXUOH]C;V(DO;?<88P"2#@$GJ<>]=I:>#/#UI9?9FTFTN"P
M_>S7,2RR3$]6=F&6)H UYW:6PE>UGC5FB)CER"H..&],=ZI>'1?KH%H-4OX+
M^]VGS;F  )(=QP1@ =,#IVKA?!Z#3K;QWH,#/]AT^>3[-&S%O+5T8E1GL"/U
MI/#UNMU\"+&"36ET:)X6$MX0/E3S6W <CDCCKWH [Z3Q!HL,[02ZO8),IVF-
MKE P/IC-:"L&4,I!4C(([UY[:W7@-M/6TTOPS)J%KM"YMM%D=2,'DNR $]><
M]^M2_":60Z!J]HR310V6L7%M;V\S;F@C&TB,GGH6- '>DA022 !R2:X;3-7\
M1^-EEO\ 1[R#1]$$C1VT[VWGS76TX+X)"JN1QP3P:[B2,2Q/&V=KJ5./0UYW
MX8U.X\ Z6OAWQ!87OV:T=Q:ZE;6SS12Q%BPW; 2K<]"* +TVL^(/"6K:?#KU
MU;:GI-_.MLM['!Y,L$K?=#J"5*G&,C&/Y]Q7COQ3UJ]U_P +H^FZ?<P6%M=1
M2?:;R)H6FESM5(T;#$?,26( XQ79>*==N+G4D\*Z-<K!?SION[PL +* ]3_O
MMT4>^>.M &3XH\>ZA#K-I;:"D3V$.HPV5_>.NY3(Y_U2>I R6/;(%=AXFU^W
M\,>'KO5[E&D2W4;8U.#(Q("J/J2/I7%^-;/2]&\+^'--TUHEMX-9M, ."3\Q
M)8GN2>2?>O0)UL;VWV7 MIX&8#;)M92PY'7C- ',V^G>-[ZW6ZNO$-GILT@W
M?8X+!94B]%+LV6/KC'M4OA?Q'J%YK6J^'M;BMQJ>FA',UMD1SQN,A@#DJ>F1
MGOQ6GKD?B.01C0;C3(1M;S#>PNYSVV[6 '?J#7*^!Y&T[Q5J^EZW!(/$URBW
M4UVTHDCNH0=JF/"KM53QMQGW.. "U!K6O^+M5OXM!N;?3-(L9VMFOI(/.DN)
M5^\$4D *.F3G/;V;>ZUX@\&7ME)KMY;ZIHEU,L$EXD @EM7;[I902I3WXQ_,
M^#X7_A6FG-SYK23F7/7=YK]?PQ4WQ96-OAAK7F8P%C(SZ^:F/UH [2O.?%'C
MW4(=9M+;04B>PAU&&RO[QUW*9'/^J3U(&2Q[9 J[K6O7EV;+POIERL&J7%LD
ME]>;^+*(@9;GJ[=%'7G/O6=XUL]+T;POX<TW36B6W@UFTP X)/S$EB>Y)Y)]
MZ /2J*;')'*NZ-U=>F5.13J "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%WH?A2\N]/;_ %=S<7,=OYH]55LG'H3BM+0?%5OK5Y<Z=+:7.GZI:@--9W(
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBD)0^D:[<1CK@#\Z[6TUW0/'.E:G8:7J"74;0&&X*(PV"16 ^\!GH?RKHJ*
M//?!OBBS\/:1!X9\3W,.F:GIP, -RWEQSQC[CHYPI&,#KGBHM6U&#Q_XFT73
M-%<W6EZ;>+?7]Z@/E;DSLC5NC$DG./Z<>A3VT%TFRXACE3^[(@8?K3TC2) D
M:*B+P%48 H Q-6\5V.C>(-)T:XBN6N=49EA:-5*+MQG<201U[ UNTUHXW=79
M%++]TD<CZ4Z@#@-1_P"2Y:-_V")?_0VK6^(VC7VO> ]3T_3<FZ=594!QYFU@
MQ7\0*ZFB@#E--^(/A:XLU$NI6VF31*!+9WK""2$@<IM;'3VK&ANH_%WQ-TG5
M]%1I-,TFWG2XO]A5)V=<"-2?O;3\W'')]J[Z:SMKEE:>WAE9>5+H&(^F:E "
M@   #@ 4 ><Z'J$'@#7-7T;6W%IIUY>/>Z=>N,1,'Y:,MT4KCOU_*G>-/$MI
MXFTJ7PMX8NH]2U'4"L4DEL?,BMXB1N=W' & 1C.>:]#DC26,I(BNAZJPR#3(
M+>"UC\NWACB3KMC4*/R% '">)=-F\-:SX=\1V5O+<66EP&QO8XUW2"W( #@#
MD[3R<?XUKS_$?PC#I_VM=<M9P1E(8'WS.>P$8^;)]P*ZFH$LK6.X-PEM"LQZ
MR",!C^/6@#E?AYI=]:Z=J.K:I UO?:Q>O>- W6%#]Q#[@?SKL:** "N.\$_\
MAOQA_P!A<_\ HM*[&FJBJ6*J 6.3@=30 ZBBB@#B/B'&=-&D>+(58R:-= S[
M1DM;2?)(/?J#[<TG@?2QJWA+4=0U*+]YXCEEN)58#(A<;47Z!,8^M=Q10!X_
MX0-YKWB+1M!OT8IX067[2Q'RR3!C'#CZ(-P/UKM/B+IDU[X5>]LA_P 3#2I5
MU"U('.Z,Y(]\KNX^E=910!PGP_G_ .$BO]:\8/&RQW\JVUFKCE8(AC]6+$^X
MKD[>TFFUZ'X:M$YLK/57OW./E^Q#$J(?7+O@_0=*]GHH Q/%VA+XD\*ZAI?'
MF31$PM_=D7E#_P!] 5QW@#4;CQGXC?Q#>1.HTRPCT]0ZX_TE@&G8#L>@^AKT
MRB@#QSQ*EW8>(M7\%6BNL?BBZAN8'0<1*^?M)/\ W[SCT->HW]Y9^&O#LUTT
M3BST^WW>7$ 6"(.@!('0>M:5(RJZE6 93P01D&@#E-8U>WU_X5:MJMJDJ076
MDW$B+* & \MNH!(_6L3P!XRTRR\'Z3I^N3QZ7<QVR"(W3"..>/'RNCGY3QC(
MSD'-=GX@TZ34?"^JZ9:!%EN;.:"('A0S(5&?09-0>'-%.G^$=+TG48H)I+:V
M2.1<;T+*,<9% '*ZMJ4/COQ1H6GZ&YN=/TN^34;V^C'[I6CSLC5NC$DG..WX
MXSIGT:X\?ZU;^/)PBHZ'2X;V4I:&''++DA"V<9SW^E>J(B1H$1551T51@"FS
MV\%S'Y<\,<J?W9%##\C0!X_XVO?#;:)&GA72[1[:UNX)K^^L+95BAC5QP74?
M,2<<#/ )-;/B;5+.T\:>%/&!E,F@^3- ]Y&I98RX(4MCL2>OL:])1$C0(BJJ
MCHJC %*RAE*L 5(P0>] '':]XTTBYT2ZM-$O(-5U&Y@>."WLW$I!((W/C[JC
MJ2<<"N!U+_DV:S_X!_Z4&O:X+:"V4K;P1Q G)$:!<G\*>\:2+MD174]F&10!
MP7B7_DL/@C_KE>_^BC7<7O\ QX7'_7)OY&IZ* /%M,GU*W^ &BR:>URD?VEA
M>O:Y\U+;SY-Y7'.>GX9KH;6?X56-FD]JFCWDCCY$V"YN9#V&ULON/O7I%0QV
MEM%,TT=O$DK?>=4 )^IH \M\':O>V0\8VEM91P>(7NY+ZVTJ<8)C*J5'!QTX
MX/6KR:G\-_$]B+G7(-(M-1VC[5%=J+>>.3'S+DX8X/H37I502V5K/(LDUM#(
MZ]&>,$C\30!PGPZ>8ZMK::9/=S^%5,8T^2Z+-\^/G$9;YB@/K[8[U5^'&KZ?
MI=]XBT2_NX[?4Y==N)([:0X=U8+M*^N<'I7IG2FF-&D5RBEUZ,1R* /._"/_
M "-/Q#_Z^4_] :KWP@_Y);HW_;?_ -'R5W%% ' >)?\ DL/@C_KE>_\ HHU#
M87DG@#Q+KD.K07']BZI>-?V]_%"TB1R/C>DFT$KR!@]./R]%KE+V#Q7I>OW-
M_IIBU?3;E5S83S>2]NP'6-\$$'J0: .7^(GBZWUSP+JEKH237,7EAKJ\:)XX
MH4# XW,!N9C@!1GJ2<8K:U77Y=!TOP^U]I\=QX=GMECU"8Q&0VYV#:Q49^4G
MKP>GTJ/6M-\4^-K5=)O]/M]$TEY%:[;[4)YIE!!V*% "@D=2?\#W:1I'&L:*
M BC:%'0#TH \J\01_#,Z=+>:7=64&IE&^R'19MLYDQ\H"1GN<=1BNGB\2W7A
M;X;V6L^*HKA[N.*,7*0JIDW,<#() S@C//7-=3%96L$C20VT,;MU9(P"?Q%2
MO&DB[9$5U/9AD4 <CXXTV\\2>#8;G2$W7EO+#J%M$^!O*_-M/O@G\:EL?B-X
M9NK+S;O4X=.N4'[^SO6\J:)NZE6P2?I75@   # %0RV=M/(LDUM#(Z_=9T!(
M^A- '$>=J?Q!T;Q'!'$+;1+F#R-,EEC*/.V.9"#R$W8QQR*E\,^.--M])M],
M\17$>CZQ9Q+#<07K"(,5&-Z,>&4XR,'^F>XJ*>UM[I0MQ!%,!R!(@;'YT >?
MWMY'X^\7Z)%HX:;1]'N?MMS?A2(WE7[D:$_>.>N.*F\-?\EA\;_]<K+_ -%"
MN^5510J@*HX  P!2T <!\5O^/#PS_P!C#:_R>N_HHH X#X,?\DSL/^NLW_HQ
MJ[^BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
' "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>img246856755_2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img246856755_2.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "= A8# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MVZBA_#0\S_WJ7R_(****V. **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^
M,*^MK3PYH;6<!.C:<28U))M4]/I7R37V39_\>-O_ -<U_E7'A5>Y[^<R:4+/
MO^A2_P"$;T+_ * NG?\ @*G^%'_"-Z%_T!=._P# 5/\ "M.BNNR/#]I/N1P6
M\-M$(K>&.*,=$C4*!^ J2BBF0%%%% '*_$3Q'_PC/@Z[NHWVW<P\BVP>=[=Q
M]!D_A7S'8:=>:I=K:V%K+<W# D1Q(68@<G@5WWQD\2?VOXJ&F029M=-!C.#P
M93]\_APOU!KJ?@=X=\FQN_$,Z?/.?L]N2/X ?F(^IP/^ FN*?[VIR]$?0X>V
M"PGM6M7_ $O\SR__ (07Q7_T+VH_^ [4?\(+XK_Z%[4?_ =J^KZ*T^JQ[G-_
M;-3^5'RA_P (+XK_ .A>U'_P':L>*2ZTO44E3?!=VLH89&"CJ?3U!%?8]?.W
MQD\._P!D^+!J4*8MM27S.!P)1PX_'AOJ3656AR+F1V8/,7B*GLYI(]U\.:U#
MXA\/66JPX"W$89E'\+=&7\""*U*\3^!WB39/>>'9WXD_TBVS_>'#K^6#^!KV
MRNNG/GBF>)BZ'L*SATZ>@5RWQ(A:?X>:TB]1!OZ=E8$_RKJ:K:A91:CIMU8S
M_P"JN8FB?Z,"#_.JDKIHQI3Y)QEV9\K^"I4A\<:&\C!5%[$"3T&6 KZQKX]U
M+3[O0]8N+&Y!CNK64H<<<@\$>QX(-?0W@;XEZ7XCL(;>_N8K35D4+)'*P593
M_>0G@Y].H^G-<F'DE>+/;S:C*HHU8:H[RBBFR2)%&TDCJB*,LS'  ]S78>"5
M=7N%M-%O[ER L5O)(2>F I-?'\,33SQPH,O(P51[DXKV?XI_$FRN--F\/Z)<
M+<&;Y;JYC.45<_<4]R>Y'&.._'"?#3P_+K_C:R&PFVM'%S.V. %.0/Q; _/T
MKBK-3FHH^ARZF\/0E5J:7_0^H****[3YX*\8^/O_ #+W_;S_ .TJ]GKQCX^_
M\R]_V\_^TJQK_P -G=EG^]1^?Y,@^ G_ !_:Y_USA_FU>W5X7\#+NVM+W6C<
MW$4(:.+;YCA<\MZU[/\ VQIG_01M/^_Z_P"-%!KV:+S.+>)E9=OR+M%4O[8T
MS_H(VG_?]?\ &C^V-,_Z"-I_W_7_ !K6Z.#EEV+M%5H=0LKF3RX+RWE?&=J2
MJQ_(&K-,336X4444""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Y0_X07Q7_ -"]J/\
MX#M7U5:J4M(58$,(U!![<5+165.DJ=[';B\;+$VYE:P4445J<04444 %9^N7
MMSI^AWEU96LEU=1Q$PPQJ6+OT48';)&?;-:%%#'%V=V?+ \"^+[^_!FT6_\
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M1/GDK!1115G.%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^%E:C_T3[Q7_ . J_P#Q5 'H%%>?_P#"RM1_Z)]XK_\  5?_ (JC_A96H_\
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M"K_\50!Z!17G_P#PLK4?^B?>*_\ P%7_ .*H_P"%E:C_ -$^\5_^ J__ !5
M'H%%>?\ _"RM1_Z)]XK_ / 5?_BJ/^%E:C_T3[Q7_P" J_\ Q5 'H%%>?_\
M"RM1_P"B?>*__ 5?_BJ/^%E:C_T3[Q7_ . J_P#Q5 'H%%>?_P#"RM1_Z)]X
MK_\  5?_ (JC_A96H_\ 1/O%?_@*O_Q5 'H%%>?_ /"RM1_Z)]XK_P# 5?\
MXJC_ (65J/\ T3[Q7_X"K_\ %4 >@45Y_P#\+*U'_HGWBO\ \!5_^*H_X65J
M/_1/O%?_ ("K_P#%4 >@45Y__P +*U'_ *)]XK_\!5_^*H_X65J/_1/O%?\
MX"K_ /%4 >@45Y__ ,+*U'_HGWBO_P !5_\ BJ/^%E:C_P!$^\5_^ J__%4
M>@45Y_\ \+*U'_HGWBO_ ,!5_P#BJ* /0**** "BBB@ HHHH **** "BBB@
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MM]0TFU$MT?DG4.J;A_"W) XY'Y>E5_A_X>\1>']:E-]8F*RGB*N?.1@&'*G
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M]12 ^:W2]T352K;[:]M9/H585[EX/\4P^)M+#G:E[#A9XAZ_WA[&LOQ_X/\
M[<M/[0LHQ_:$"\J/^6R#M]1V_*O)]%UB[T#58[ZU.)$.'0]'7NII@=7\6?\
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MIZ8HKSX*6. "3[44Q"5]-6W_ !ZP_P"XO\J\^_X5'8?]!2Y_[]K7HD:>7$B
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J/C:#[*./SS2 Y_X<>$/W,NJZG;_),FR"*1>JY!+D?@,?C[45Z=10!__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
